BioMed Research International / 2020 / Article / Tab 1

Clinical Study

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Table 1

General characteristics of patients with COVID-19.

VariablesNumber of patientsProportion (%)

 0-6 years00
 7-17 years412.1
 18-40 years618.2
 41-65 years1854.6
 ≥66 years515.6
Clinical classification
Lymphocyte absolute value after admission (normal: /L)
CD3+ T cell after admission (normal: 1027-2086/μL)
CD4+ T cell after admission (normal: 706-1125/μL)
CD8+ T cell after admission (normal: 323-836/μL)
Treated with glucocorticoids

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.